SRS Acquiom analyzes the deal terms of 735 private-target acquisitions valued at $137 billion, to assist you in deal structuring and negotiation and bring you a robust view of the private-target M&A landscape.

Key Findings Include:

  • Correlations in equity capital invested and investor returns
  • Changes to indemnification terms since Cigna v. Audax
  • Drafting trends in closing conditions and dispute-resolution provisions
  • And many more – over 200 deal terms published
Related Insights